Abingworth

Quick Facts

AUM

$1.5B

AUM Category

$1B-$5B

Typical Ticket Size

$10M - $50M

Headquarters

London, UK

Founded

1984

Team Size

50-100

About Abingworth

Abingworth is a leading venture capital and growth equity firm that specializes in the life sciences sector. Founded in 1984, the firm has established a strong reputation for its deep expertise in biotechnology, pharmaceuticals, and medical devices. Abingworth employs a distinctive investment philosophy centered on collaborating closely with entrepreneurs and management teams to identify and address critical market needs. The firm typically seeks to invest in companies at various stages of development, from early-stage ventures to later-stage growth companies, with a focus on those demonstrating innovative technologies or compelling business models that can capture significant market opportunities. The firm's sector expertise is particularly pronounced in the life sciences arena, where Abingworth actively targets companies that are pioneering advancements in drug development, diagnostics, and therapeutic solutions. The firm has a robust track record of identifying promising candidates within the healthcare landscape and often partners with organizations that have a clear path to commercialization. Abingworth's investment strategy is characterized by a strong emphasis on scientific rigor and a thorough understanding of regulatory pathways, which positions them to effectively support the growth of their portfolio companies through strategic guidance and operational oversight. What distinguishes Abingworth in the private equity landscape is its dual focus on both venture capital and growth equity investments, allowing it to leverage diverse opportunities across the life sciences continuum. Additionally, the firm is known for its collaborative approach, fostering strong relationships with management teams and other stakeholders, which enhances its ability to drive value creation. Abingworth’s experienced team includes professionals with diverse backgrounds in science, medicine, and business, enabling a comprehensive evaluation of potential investments. For interim executives considering a partnership with Abingworth, it is essential to recognize the firm's commitment to strategic collaboration and its patient, long-term investment horizon. Successful partnerships with Abingworth often involve aligning with their vision for growth and innovation while bringing operational expertise that can enhance company performance and execution. Interim executives looking to engage with Abingworth should be prepared to contribute to a dynamic and evolving environment characterized by a strong focus on scientific excellence and market-driven strategies.

Investment Focus

Sectors: Healthcare

Investment Stages: Venture, Growth

Portfolio Focus: HealthTech

Regional Offices

• San Francisco
• Boston

Connect with Abingworth

• Website

Frequently Asked Questions

Is Abingworth a private equity firm?

Yes, Abingworth is a private equity firm headquartered in London, UK, founded in 1984.

What is Abingworth's AUM (assets under management)?

Abingworth manages approximately $1.5B in assets under management.

What is Abingworth's typical ticket size?

Abingworth typically invests $10M - $50M per deal.

Where is Abingworth headquartered?

Abingworth is headquartered in London, UK. Regional offices include San Francisco, Boston.

What sectors does Abingworth invest in?

Abingworth invests across Healthcare.

What investment stages does Abingworth focus on?

Abingworth focuses on Venture, Growth investments.

When was Abingworth founded?

Abingworth was founded in 1984.